SCHLAGWORTE: Regina Hodits
Nuclidium: CHF 26 million Series B extension round
Nuclidium, a clinical-stage radiopharmaceutical company, has announced the successful closing of an oversubscribed CHF 26 million (EUR 28.4 million) Series B extension round, bringing...
The right consortium makes all the difference
Telling a catchy equity story and starting to address different investor groups at an early company development stage – how European life sciences companies...